ELAACC 2026 – European Left Atrial Appendage Closure Club

Where LAAC Practice Is Defined, Not Just Discussed

Europe’s dedicated LAAC consensus forum — bringing together leading operators to challenge practice, interpret emerging evidence, and shape the future of left atrial appendage closure.

ACCESS ALL THE CONTENT ON-DEMAND

WHY ELAACC?

A different kind of meeting. A true expert forum.

ELAACC is not a traditional congress. It is a closed, expert-led club format designed to deliver something the field critically needs:
clear, practical consensus in a rapidly evolving area of cardiology.

While many meetings present data, ELAACC is where:

  • Evidence is interrogated

  • Practice is challenged

  • Consensus is built

What makes ELAACC unique

  • Consensus-first approach
    Structured discussions designed to produce aligned clinical positions

  • Guideline-shaping ambition
    Outputs intended to inform real-world practice and future recommendations

  • Operator-level discussion
    Focused on decision-making, technique, and complications—not theory

  • True multidisciplinary collaboration
    Interventional cardiology, electrophysiology, and imaging working as one

WHY 2026 MATTERS?

A defining moment for LAAC

Left atrial appendage closure is entering a new phase.

With landmark trials such as CHAMPION-AF and CLOSURE-AF, expanding indications, and rapid technological evolution, the field is approaching a critical inflection point:

  • Where does LAAC sit vs DOACs?

  • How should patients be selected moving forward?

  • What defines optimal procedural strategy and imaging?

  • How do we standardise care across centres?

ELAACC 2026 is designed to address these questions directly—through structured debate, expert voting, and consensus building.

Join us in our commitment to promoting best practices, fostering collaboration, and ultimately improving patient outcomes.

Together, we can shape the future of left atrial appendage closure.

WHAT YOU WILL GAIN

By participating in ELAACC 2026, you will:

  • Gain clarity on evolving indications for LAAC

  • Understand how leading centres interpret new trial data

  • Refine your procedural and imaging strategy

  • Benchmark your practice against European experts

  • Contribute to consensus that will shape future guidelines

PROGRAMME HIGHLIGHTS

The 2026 programme is built around structured debate and consensus generation, including:

  • Deep-dive analysis of CHAMPION-AF and CLOSURE-AF

  • Case-based controversies and real-world decision-making

  • Interactive voting with real-time consensus development

  • AI and procedural evolution in LAAC

  • US–EU registry collaboration updates

  • Expert panel debates on unresolved clinical questions

ELAACC 2.0

From discussion to definition

ELAACC 2026 marks the evolution of the meeting into a true consensus platform.

What’s new:

  • More structured debates focused on key clinical questions

  • Expanded consensus output with defined takeaways

  • Stronger alignment between discussion → conclusion → publication

ELAACC is no longer just a meeting.
It is a platform designed to produce direction for the field.

OUTPUTS & IMPACT

ELAACC delivers tangible outcomes that extend beyond the meeting itself:

  • Consensus statements and publications

  • Contributions to guideline development

  • Registry insights and updates

  • Identification of key evidence gaps and research priorities

THE CLUB

Expert-led. Invite-only. Globally accessible.

The in-person meeting is intentionally limited to a select group of experienced operators, enabling open, high-level discussion.

Through the live stream, ELAACC extends its reach globally—ensuring that:

  • Insights are shared widely

  • Best practices are accessible

  • The impact goes far beyond the room

LIVE STREAM ACCESS

🎥 Global Access – Complimentary Registration Required

Friday 17 April 2026 | 13:00–19:15 CET
Saturday 18 April 2026 | 08:30–16:00 CET

  • Full access to all live sessions

  • On-demand viewing after the meeting

  • Secure streaming platform

MEET THE ELAACC COMMITTEE:

  • Dr Adel Aminian

    CHU Charleroi, Belgium

  • Dr Sergio Berti

    Fondazione CNR Regione Toscana, Massa, Italy.

  • Dr Ignacio Cruz-González

    Hospital Universitario de Salamanca, IBSAL, CIBER-CV, Salamanca, Spain.

  • Dr Tom De Potter

    Cardiovascular Center, OLV Hospital, Moorselbaan, Aalst, Belgium

  • Dr Ole De Backer

    Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

  • Dr Xavier Freixa

    Institut Clinic Cardiovascular, Hospital Clínic, Barcelona, Spain.

  • Dr Philippe Garot

    Institut Cardiovasculaire Paris Sud (ICPS) Hôpital J. Cartier, Massy, France

  • Dr Jens Erik Nielsen-Kudsk

    Aarhus University Hospital, Aarhus, Denmark.

  • Dr Lorenz Räber

    Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

  • Dr Nina Wunderlich

    Asklepios Klinik Langen, Frankfurt, Germany

PARTNERS

ELAACC 2026 was supported by leading innovators in structural heart and left atrial appendage closure.

For 2027 partnership opportunities, please contact us.
CONTACT US

Advancing practice. Building consensus. Improving outcomes.

ELAACC is committed to driving progress in left atrial appendage closure through collaboration, evidence, and expert dialogue.